Who Gets The Vaccine First? And How Will They Get It?
A health care worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus pandemic by the U.S. Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey. Dogukan Keskinkilic/Anadolu Agency via Getty Images hide caption
A health care worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus pandemic by the U.S. Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey.
Dogukan Keskinkilic/Anadolu Agency via Getty ImagesDeveloping a safe and effective coronavirus vaccine will be crucial to getting the pandemic under control. Also important, distributing it throughout the country once it's been approved. NPR science reporter Pien Huang tells us which high risk groups will get it first, how the vaccine will be distributed (including some challenges), and who's footing the bill for all of this.
Email the show at shortwave@npr.org.
This episode was edited by Viet Le, and fact-checked by Ariela Zebede.